FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311753511> ?p ?o ?g. }

• W4311753511 abstract "Abstract Background Dual antiplatelet therapy with aspirin and a P2Y12 receptor inhibitor is the standard of care in patients with acute coronary syndromes. The optimal timing of the administration of oral P2Y12 inhibitors has been largely debated, particularly among patients with non-ST-segment elevation myocardial infarction (NSTEMI). The latest European Society of Cardiology guidelines, based on recent scientific evidence, do not recommend routine pre-treatment with a P2Y12 inhibitor before coronary angiography. However, the impact of pre-treatment on the incidence of peri-procedural myocardial infarction (MI) and myocardial injury has never been explored. Purpose To evaluate the impact of pre-treatment with a P2Y12 receptor inhibitor on periprocedural myocardial infarction and injury in NSTEMI patients undergoing invasive treatment. Methods We evaluated all consecutive patients admitted to our coronary care unit from 2016 to 2021 affected by NSTEMI undergoing invasive management with percutaneous coronary intervention (PCI). We enrolled only patients with stable (≤ 20% variation) or falling pre-procedure baseline cardiac troponin (cTn) values. The entire population was divided into two groups: patients pre-treated with dual antiplatelet therapy (an oral P2Y12 inhibitor in adjunct to aspirin) before performing coronary angiography (upstream group) and patients who started an oral P2Y12 inhibitor only after PCI (downstream group). All patients received aspirin and anticoagulant therapy before coronary angiography. The primary endpoint was the incidence rate of periprocedural MI and myocardial injury according to the fourth universal definition of myocardial infarction. Finally, a safety endpoint of major and minor bleeding according to Thrombolysis in Myocardial Infarction (TIMI) criteria was evaluated for all bleeding episodes during hospitalization. Results A total of 878 patients with NSTEMI undergoing PCI and with pre-procedure stable cTn levels were analyzed: 615 (70%) constituted the upstream group. The mean age of the study population was 70.1±12.5 years and 71.3% were males. There were no significant differences regarding traditional cardiovascular risk factors, comorbidities, cTn and hemoglobin levels between the two groups. After PCI, the rate of periprocedural myocardial injury and MI did not significantly differ between the upstream and downstream groups (19.5% vs 24.7%, p=0.08 and 17.6% vs 19.4%, p=0.5, respectively). A trend of lower periprocedural myocardial injury and MI cumulative incidence was observed in the upstream group (37.1% vs 44.1%, p=0.051). Notably, major and minor bleedings during hospitalization occurred more frequently in the upstream group compared to the downstream one (5.2% vs 1.9%, p=0.02). Conclusions Among NSTEMI patients undergoing invasive management and with stable pre-procedure cTn levels, pretreatment with an oral P2Y12 inhibitor did not reduce the rate of periprocedural MI and myocardial injury but was associated with an increase in major and minor bleeding complications during hospitalization." @default.
• W4311753511 created "2022-12-28" @default.
• W4311753511 creator A5001037544 @default.
• W4311753511 creator A5010241678 @default.
• W4311753511 creator A5021628173 @default.
• W4311753511 creator A5030742489 @default.
• W4311753511 creator A5033930135 @default.
• W4311753511 creator A5039188583 @default.
• W4311753511 creator A5041787832 @default.
• W4311753511 creator A5045996328 @default.
• W4311753511 creator A5049040367 @default.
• W4311753511 creator A5049432842 @default.
• W4311753511 creator A5052037776 @default.
• W4311753511 creator A5063677699 @default.
• W4311753511 creator A5065469571 @default.
• W4311753511 creator A5067676269 @default.
• W4311753511 creator A5068323275 @default.
• W4311753511 creator A5078420807 @default.
• W4311753511 creator A5080923345 @default.
• W4311753511 creator A5084430285 @default.
• W4311753511 creator A5084550471 @default.
• W4311753511 date "2022-12-14" @default.
• W4311753511 modified "2023-10-14" @default.
• W4311753511 title "1031 IMPACT OF PRE-TREATMENT WITH A P2Y12 RECEPTOR INHIBITOR ON PERIPROCEDURAL MYOCARDIAL INFARCTION AND MYOCARDIAL INJURY IN NSTEMI" @default.
• W4311753511 doi "https://doi.org/10.1093/eurheartjsupp/suac121.535" @default.
• W4311753511 hasPublicationYear "2022" @default.
• W4311753511 type Work @default.
• W4311753511 citedByCount "0" @default.
• W4311753511 crossrefType "journal-article" @default.
• W4311753511 hasAuthorship W4311753511A5001037544 @default.
• W4311753511 hasAuthorship W4311753511A5010241678 @default.
• W4311753511 hasAuthorship W4311753511A5021628173 @default.
• W4311753511 hasAuthorship W4311753511A5030742489 @default.
• W4311753511 hasAuthorship W4311753511A5033930135 @default.
• W4311753511 hasAuthorship W4311753511A5039188583 @default.
• W4311753511 hasAuthorship W4311753511A5041787832 @default.
• W4311753511 hasAuthorship W4311753511A5045996328 @default.
• W4311753511 hasAuthorship W4311753511A5049040367 @default.
• W4311753511 hasAuthorship W4311753511A5049432842 @default.
• W4311753511 hasAuthorship W4311753511A5052037776 @default.
• W4311753511 hasAuthorship W4311753511A5063677699 @default.
• W4311753511 hasAuthorship W4311753511A5065469571 @default.
• W4311753511 hasAuthorship W4311753511A5067676269 @default.
• W4311753511 hasAuthorship W4311753511A5068323275 @default.
• W4311753511 hasAuthorship W4311753511A5078420807 @default.
• W4311753511 hasAuthorship W4311753511A5080923345 @default.
• W4311753511 hasAuthorship W4311753511A5084430285 @default.
• W4311753511 hasAuthorship W4311753511A5084550471 @default.
• W4311753511 hasBestOaLocation W43117535111 @default.
• W4311753511 hasConcept C126322002 @default.
• W4311753511 hasConcept C164705383 @default.
• W4311753511 hasConcept C168563851 @default.
• W4311753511 hasConcept C203092338 @default.
• W4311753511 hasConcept C2777028646 @default.
• W4311753511 hasConcept C2777628954 @default.
• W4311753511 hasConcept C2777698277 @default.
• W4311753511 hasConcept C2777785093 @default.
• W4311753511 hasConcept C2777849778 @default.
• W4311753511 hasConcept C2777995511 @default.
• W4311753511 hasConcept C2779837110 @default.
• W4311753511 hasConcept C2780400711 @default.
• W4311753511 hasConcept C2908647359 @default.
• W4311753511 hasConcept C36036425 @default.
• W4311753511 hasConcept C45393284 @default.
• W4311753511 hasConcept C49059817 @default.
• W4311753511 hasConcept C500558357 @default.
• W4311753511 hasConcept C71924100 @default.
• W4311753511 hasConcept C99454951 @default.
• W4311753511 hasConceptScore W4311753511C126322002 @default.
• W4311753511 hasConceptScore W4311753511C164705383 @default.
• W4311753511 hasConceptScore W4311753511C168563851 @default.
• W4311753511 hasConceptScore W4311753511C203092338 @default.
• W4311753511 hasConceptScore W4311753511C2777028646 @default.
• W4311753511 hasConceptScore W4311753511C2777628954 @default.
• W4311753511 hasConceptScore W4311753511C2777698277 @default.
• W4311753511 hasConceptScore W4311753511C2777785093 @default.
• W4311753511 hasConceptScore W4311753511C2777849778 @default.
• W4311753511 hasConceptScore W4311753511C2777995511 @default.
• W4311753511 hasConceptScore W4311753511C2779837110 @default.
• W4311753511 hasConceptScore W4311753511C2780400711 @default.
• W4311753511 hasConceptScore W4311753511C2908647359 @default.
• W4311753511 hasConceptScore W4311753511C36036425 @default.
• W4311753511 hasConceptScore W4311753511C45393284 @default.
• W4311753511 hasConceptScore W4311753511C49059817 @default.
• W4311753511 hasConceptScore W4311753511C500558357 @default.
• W4311753511 hasConceptScore W4311753511C71924100 @default.
• W4311753511 hasConceptScore W4311753511C99454951 @default.
• W4311753511 hasIssue "Supplement_K" @default.
• W4311753511 hasLocation W43117535111 @default.
• W4311753511 hasOpenAccess W4311753511 @default.
• W4311753511 hasPrimaryLocation W43117535111 @default.
• W4311753511 hasRelatedWork W14452866 @default.
• W4311753511 hasRelatedWork W2053114803 @default.
• W4311753511 hasRelatedWork W2324693508 @default.
• W4311753511 hasRelatedWork W2778371664 @default.
• W4311753511 hasRelatedWork W2788692878 @default.
• W4311753511 hasRelatedWork W2790813266 @default.
• W4311753511 hasRelatedWork W2979957865 @default.
• W4311753511 hasRelatedWork W4224250870 @default.
• W4311753511 hasRelatedWork W4311753511 @default.

• next